• Mycophenolate shows efficacy, tolerability in morphea

    1 month ago - By Healio

    A retrospective analysis showed that patients with recalcitrant morphea benefited from mycophenolate therapy, with tolerable adverse events.
    “First-line systemic therapy for morphea includes methotrexate with or without systemic corticosteroids,” Megan Arthur, MD, of the department of dermatology at the University of Nebraska, Omaha, and colleagues wrote. “When this regimen is ineffective, not tolerated or contraindicated, a trial of mycophenolate mofetil or mycophenolic acid -referred to herein as mycophenolate - is recommended; however, evidence to support this
    Read more ...